466 related articles for article (PubMed ID: 7563265)
1. Human T-lymphotropic virus type-I, and hepatitis A, B and C viruses in Nepal: a serological survey.
Nakashima K; Kashiwagi S; Noguchi A; Hirata M; Hayashi J; Kawasaki T; Uezono K; Itoh K; Acharya GP; Ogata M
J Trop Med Hyg; 1995 Oct; 98(5):347-50. PubMed ID: 7563265
[TBL] [Abstract][Full Text] [Related]
2. A ten year serological survey of hepatitis A, B and C viruses infections in Nepal.
Sawayama Y; Hayashi J; Ariyama I; Furusyo N; Kawasaki T; Kawasaki M; Itoh K; Acharya GP; Kashiwagi S
J Epidemiol; 1999 Nov; 9(5):350-4. PubMed ID: 10616269
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of antibodies to hepatitis A, hepatitis B and hepatitis C viruses in the German population].
Thierfelder W; Meisel H; Schreier E; Dortschy R
Gesundheitswesen; 1999 Dec; 61 Spec No():S110-4. PubMed ID: 10726407
[TBL] [Abstract][Full Text] [Related]
4. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis.
Collenberg E; Ouedraogo T; Ganamé J; Fickenscher H; Kynast-Wolf G; Becher H; Kouyaté B; Kräusslich HG; Sangaré L; Tebit DM
J Med Virol; 2006 May; 78(5):683-92. PubMed ID: 16555290
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy).
Majori S; Baldo V; Tommasi I; Malizia M; Floreani A; Monteiro G; Ferrari A; Accordini A; Guzzo P; Baldovin T
J Travel Med; 2008; 15(5):323-7. PubMed ID: 19006505
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of markers of hepatitis B in the adult German population.
Jilg W; Hottenträger B; Weinberger K; Schlottmann K; Frick E; Holstege A; Schölmerich J; Palitzsch KD
J Med Virol; 2001 Feb; 63(2):96-102. PubMed ID: 11170044
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
[TBL] [Abstract][Full Text] [Related]
12. HBV and HCV infection in Japanese dental care workers.
Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
[TBL] [Abstract][Full Text] [Related]
13. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses.
Candotti D; Mundy C; Kadewele G; Nkhoma W; Bates I; Allain JP
J Med Virol; 2001 Sep; 65(1):1-5. PubMed ID: 11505436
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch community.
Chapman BA; Burt MJ; Frampton CM; Collett JA; Yeo KH; Wilkinson ID; Cook HB; Barclay MJ; Ross AG; George PM
N Z Med J; 2000 Sep; 113(1118):394-6. PubMed ID: 11062814
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors.
Meffre C; Le Strat Y; Delarocque-Astagneau E; Dubois F; Antona D; Lemasson JM; Warszawski J; Steinmetz J; Coste D; Meyer JF; Leiser S; Giordanella JP; Gueguen R; Desenclos JC
J Med Virol; 2010 Apr; 82(4):546-55. PubMed ID: 20166185
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to hepatitis B virus and hepatitis C virus in residential detoxification clients in Jamaica.
Smikle MF; Dowe G; Williams EM; Thesiger C
Hum Antibodies; 2000; 9(4):231-3. PubMed ID: 11341177
[TBL] [Abstract][Full Text] [Related]
17. Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance.
Kishihara Y; Furusyo N; Kashiwagi K; Mitsutake A; Kashiwagi S; Hayashi J
J Infect Dis; 2001 Nov; 184(9):1114-9. PubMed ID: 11598833
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibody to human T-cell lymphotropic virus type I/II in people of Caribbean origin in Toronto.
Chiavetta J; Nusbacher J; Tam F; Wall A; Steaffens J; Lee H
CMAJ; 1992 Nov; 147(10):1493-8. PubMed ID: 1423089
[TBL] [Abstract][Full Text] [Related]
19. Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children.
Martinson FE; Weigle KA; Mushahwar IK; Weber DJ; Royce R; Lemon SM
J Med Virol; 1996 Mar; 48(3):278-83. PubMed ID: 8801290
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of infection by hepatitis viruses in a rural area. Analysis according to risk factors and alcohol consumption].
Nalpas B; Zylberberg H; Dubois F; Presles MA; Gillant JC; Lienard M; Delemotte B; Bréchot C
Gastroenterol Clin Biol; 2000 May; 24(5):536-40. PubMed ID: 10891742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
